| abstract |
A compound represented by any one of the following structural formulas: ** Formula ** I or a pharmaceutically acceptable salt thereof, for use in the treatment of a condition selected from the group consisting of prostate cancer, renal cell carcinoma, hepatoma, lung carcinoma, breast cancer, colon cancer, neuroblastoma, glioblastoma multiforme, squamous cell carcinoma that involves a reorganization of NUT, midline NUT carcinoma and non-small cell lung carcinoma. |